|
- 2018
不同孕期特异性甲状腺激素水平探讨
|
Abstract:
摘要 目的:探讨各孕期妇女甲状腺激素水平的变化,建立本地区孕期特异性甲状腺激素水平参考值范围.方法:筛选产检并分娩的各孕期正常孕妇共600例,采用化学发光法测定促甲状腺激素(TSH)、游离甲状腺素(FT4)、游离三碘甲状腺原氨酸(FT3),制定各孕期特异性甲状腺激素水平参考值范围.收集各孕期孕妇3 770例,评估本研究参考值,并与2011年及2017年美国甲状腺医师学会(ATA)指南的诊断标准进行比较.结果:①妊娠早、中、晚各期血清TSH的质量浓度中位数及97.5%参考范围分别为1.06 mIU/L(0.013~3.01 mIU/L),1.31 mIU/L(0.35~4.08 mIU/L),1.51 mIU/L(0.20~4.05 mIU/L),孕早期TSH值显著低于孕中、晚期.②以2017年ATA标准对妊娠中、晚期亚甲减的诊断率与本研究制定的参考值范围相似,但对早孕期亚甲减的诊断,漏诊率高达68.4%.③约69%的孕妇第一次检查甲状腺功能在孕中期,孕早期监测者仅占约14%.结论:①TSH值在早孕期明显低于中晚孕期,不建议使用4.0 mIU/L TSH质量浓度值作为本地区早孕期TSH参考上限.②本地区早孕期筛查率低,应加强宣教,提高早孕期检测率.
[1] | LIU H, SHAN Z, LI C, et al.Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study[J]. Thyroid, 2014, 24(11): 1642-1649. |
[2] | KOREVAAR T I, SCHALEKAMP-TIMMERMANS S, DE RIJKE Y B, et al. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study[J]. J Clin Endocrinol Metab, 2013, 98(11): 4382-4390. |
[3] | BALOCH Z, CARAYON P, CONTE-DEVOLX B, et al.Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease[J]. Thyroid, 2003, 13(1): 3-126. |
[4] | 中华医学会内分泌学分会,中华医学会围产医学分会. 妊娠和产后甲状腺疾病诊治指南[J]. 中华围产医学杂志. 2012(7): 385-403. |
[5] | ENDOCRINOLOGY BRANCH OF CHINESE MEDICAL ASSOCIATION, CHINESE MEDICAL ASSOCIATION PERINATAL MEDICINE BRANCH. Guidelines for diagnosis and treatment of pregnancy and postpartum thyroid diseases[J]. Chinese Journal of Perinatal Medicine, 2012(7): 385-403. |
[6] | 黄璐,罗丹,王利民,等. 成都地区妊娠期特异性甲状腺激素水平参考值范围的探讨及临床分析[J]. 现代妇产科进展, 2016(4): 269-272. |
[7] | HUANG L, LUO D, WANG L M, et al.Establishing the reference range of pregnancy-specific thyroid hormone levels in chengdu area[J]. Progress in Obstetrics and Gynecology, 2016(4): 269-272. |
[8] | 叶青,赖有行,周晓莹,等. 不同妊娠期女性甲状腺激素水平变化分析[J]. 国际检验医学杂志, 2014(19): 2599-2601. |
[9] | LI C, SHAN Z, MAO J, et al.Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women?[J]. J Clin Endocrinol Metab, 2014, 99(1): 73-79. |
[10] | STAGNARO-GREEN A, ABALOVICH M, ALEXANDER E, et al.Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum[J]. Thyroid, 2011, 21(10): 1081-1125. |
[11] | ALEXANDER E K, PEARCE E N, BRENT G A, et al.2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum[J]. Thyroid, 2017, 27(3): 315-389. |
[12] | ABALOVICH M, GUTIERREZ S, ALCARAZ G, et al.Overt and subclinical hypothyroidism complicating pregnancy[J]. Thyroid, 2002, 12(1): 63-68. |
[13] | LEUNG A S, MILLAR L K, KOONINGS P P, et al.Perinatal outcome in hypothyroid pregnancies[J]. Obstet Gynecol, 1993, 81(3): 349-353. |
[14] | YE Q, LAI Y X, ZHOU X Y, et al.Analysis of thyroid hormones changes in pregnant women of different gestation[J]. International Journal of Laboratory Medicine, 2014(19): 2599-2601. |
[15] | 李晨阳,滕卫平,尚涛. 甲状腺激素与妊娠[J]. 中华内分泌代谢杂志, 2003(2): 82-84. |
[16] | LI C Y, TENG W P, SHANG T.Thyroid hormone and pregnancy[J]. Chinese Journal of Endocrinology and Metabolism, 2003(2): 82-84. |
[17] | TENG W, SHAN Z, TENG X, et al.Effect of iodine intake on thyroid diseases in China[J]. N Engl J Med, 2006, 354(26): 2783-2793. |